Skip to main content
. 2024 May 31;16(11):9547–9557. doi: 10.18632/aging.205882

Figure 4.

Figure 4

Neratinib reduced the levels of telomerase activity in AU565 cells. (A) Cells were stimulated with Neratinib (1, 2.5, 5 μM) for 7 days. The telomerase activity was assayed; (B) Cells were stimulated with Neratinib (1, 2.5, 5 μM) for 14 days. The telomerase activity was assayed (^, ^^, ^^^, P<0.05, 0.01, 0.005 vs. vehicle group).